Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
The EBC Recovery Study is a research trial that aims to understand how music and language might help patients with severe brain injuries, specifically those who are unconscious. Researchers want to see if patients who show some brain response to these sounds, detected through a simple test called an electroencephalogram (EEG), have better chances of waking up and recovering compared to those who do not show such responses. This study is currently looking for participants and includes adults aged 18 and older who are in the intensive care unit and have a low level of consciousness.
To be eligible for the study, participants must be adults with a Glasgow Coma Scale score of less than 8, meaning they do not respond to commands. They must also have tested negative for COVID-19 upon arrival at the hospital. Healthy volunteers aged 18 and older can also participate. It's important to note that pregnant women, individuals under 18, and patients who have had a cardiac arrest cannot join the study. Participants can expect to undergo assessments to see how their brains respond to music and language, helping researchers learn more about recovery from brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For ABI Participants
- • ABI adult (18 years and older) patients who are admitted to the intensive care unit
- • Unconscious with Glasgow Coma Scale (GCS) \<8 on presentation and unable to follow bedside commands.
- • A negative COVID-19 test on arrival
- For Healthy Volunteers:
- • 18 years and older
- Exclusion Criteria:
- For All Participants:
- • \<18 years of age
- • Pregnant woman
- • Patients with cardiac arrest on presentation
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Miami, Florida, United States
Patients applied
Trial Officials
Ayham Alkhachroum, MD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials